NCT02171442View on ClinicalTrials.gov

Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2002

Conditions
Healthy
Interventions
DRUG

BIBR 953 ZW Intravenously

5 mg, 2.8 MBq (76 µCi)

DRUG

BIBR 1048 Oral Solution

200 mg free base, 2.8 MBq (76 µCi)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02171442 - Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter